SECsense Logo

Outlook Therapeutics, Inc. 8-K Report Summary - January 16, 2025 Filing

$OTLK
Form 8-K
Filed on: 2025-01-16
Source
Outlook Therapeutics, Inc. 8-K Report Summary - January 16, 2025 Filing

Here is the key information extracted from the provided financial report section:

  1. Filing Information:
  • Company Name: Outlook Therapeutics, Inc.
  • CIK: 0001649989
  • SEC Filing Type: 8-K
  • Filing Date: January 16, 2025
  1. Company Identifiers:
  • Entity Type: Delaware Corporation
  • SEC Central Index Key (CIK): 0001649989
  • IRS Employer Identification Number (EIN): 38-3982704
  1. Company Address:
  • Location: 111 S. Wood Avenue Unit #100, Iselin, NJ 08830
  • Phone Number: 609-619-3990
  1. Securities Information:
  • Common Stock Ticker Symbol: OTLK
  • Exchange: NASDAQ
  1. Reporting Period:
  • Context ID: AsOf2025-01-16
  • Start Date: January 16, 2025
  • End Date: January 16, 2025
  1. Units of Measure:
  • Monetary Unit: USD (United States Dollar)
  • Shares: The report indicates the use of shares as a unit of measure but does not provide specific share counts or financial metrics in this excerpt.

Insights:

  • The report appears to be a current report (8-K), which is typically used to disclose unscheduled material events or corporate changes.
  • The filing date coincides with the reporting period, suggesting the report may be related to a significant event or announcement that occurred on this date.
  • The company is publicly traded on NASDAQ, indicating it is subject to SEC regulations and reporting requirements.
  • The provided address and contact information can be useful for stakeholders wishing to inquire further or verify details.

This analysis summarizes the essential details contained within the provided section of the financial report, focusing on the company’s identity, filing specifics, and relevant securities information.